Alpha Tau Medical (DRTS) Profit After Tax (2021 - 2026)

Alpha Tau Medical has disclosed Profit After Tax across 6 years of filings, most recently posting $22.9 million for Q1 2026.

• Profit After Tax for Q1 2026 came in at $22.9 million, up 163.94% year-over-year; the trailing twelve-month figure through Mar 2026 was $56.9 million (up 75.22% YoY), and the FY2025 annual result was $42.6 million, up 34.26% from the prior year.
• Profit After Tax came in at $22.9 million for Q1 2026 at Alpha Tau Medical, up from $12.1 million in the prior quarter.
• In the past five years, Profit After Tax ranged from a high of $25.7 million in Q1 2022 to a low of $2.0 million in Q2 2022.
• The 5-year median for Profit After Tax is $8.2 million (2023), against an average of $9.4 million.
• Across the five-year window, Profit After Tax slumped 71.37% in 2022 and jumped 334.87% in 2023, its largest moves.
• Alpha Tau Medical's Profit After Tax stood at $3.4 million in 2022, then soared by 116.87% to $7.4 million in 2023, then climbed by 28.66% to $9.5 million in 2024, then increased by 28.07% to $12.1 million in 2025, then soared by 89.02% to $22.9 million in 2026.
• The last three Profit After Tax figures came in at $22.9 million (Q1 2026), $12.1 million (Q4 2025), and $11.7 million (Q3 2025), per Business Quant data.